Searching map area
Carboplatin
? TBD
Medication used to treat cancer
Join to rate
Ratings
0
Nobody has rated this yet. Be the first!
Subject of
9
Carboplatin allergy and IgE regulation
scientific article published on 25 February 2016
Treatment with paclitaxel plus carboplatin, alone or with irradiation, of advanced or recurrent endometrial carcinoma
scientific article published on 22 September 2006
Carboplatin desensitization
scientific article published on 01 August 2004
Carboplatin desensitization
scientific article published on 01 November 2007
HNF1β drives glutathione (GSH) synthesis underlying intrinsic carboplatin resistance of ovarian clear cell carcinoma (OCCC).
scientific article published on 31 October 2015
Phase Ib with expansion study of olaparib plus weekly (Metronomic) carboplatin and paclitaxel in relapsed ovarian cancer patients
scientific article published on 29 January 2019
Phase II study of intraperitoneal submicron particle paclitaxel (SPP) plus IV carboplatin and paclitaxel in patients with epithelial ovarian cancersurgery
scientific article published on 28 August 2020
Carboplatin in BRCA1/2-mutated and triple-negative breast cancer BRCAness subgroups: the TNT Trial
scientific article published on 30 April 2018
A systematic review comparing cisplatin and carboplatin plus paclitaxel-based chemotherapy for recurrent or metastatic cervical cancer
scientific article published on 31 January 2014
Lists
0
Join to rate

Carboplatin, sold under the brand name Paraplatin among others, is a chemotherapy medication used to treat a number of forms of cancer. This includes ovarian cancer, lung cancer, head and neck cancer, brain cancer, and neuroblastoma. It is administered by injection into a vein sometimes via a port.

Instance of
type of chemical entity
Subclass of
Chemical compound
Manufacturer
Pfizer
Wikidata